Rising incidence of hematological disorders and surgical procedures has led to growth in demand for platelets and plasma products for efficient treatment and improvement in survival rates. In recent times, most blood banks split the whole blood into its components to prevent transfusion associated circulatory overload (TACO) contributed by transfusion of extra plasma. This restriction makes the usage of whole blood transfusion less common among doctors who are insisting on transfusing blood components for treatment of diseases. Upsurge in the preference toward usage of blood components has witnessed increased demand of advanced blood component separating technologies in the near future. Researchers, healthcare practitioners, and manufacturers worldwide are introducing solutions that demand minimum human intervention and allow agility in the separation process. Companies are engaged in the development of advanced instruments for the easy preparation of blood components.
Blood bank centrifuges
These are the backbone for any blood-banking lab. It is vital that the centrifuges are reliable and able to provide fully reproducible and traceable data with every spin. With downstream patient-safety implications, separation of whole blood into its components needs to be tightly regulated and compliant with good manufacturing practices (GMP). Centrifuges play an integral role in preserving the quality of blood components for storage and eventual transfusion. While the centrifuges required to spin blood collection bags are typically larger, they must be accessible by all workers and meet specific safety standards. Moreover, since blood banks function as production facilities, high-throughput capabilities that deliver run-to-run reproducibility while maintaining sample integrity are essential to ensuring processes run continuously. A lot of companies supply a range of centrifuges for blood component separation to prominent independent, government and charitable blood banks, private and government hospitals, and medical institutions across India, and globally.
With the current advances in healthcare delivery, judicious access to safe blood and blood products remains a challenge. There exists tremendous scope in India to address the healthcare needs of its ever-growing population to improve the quality of life for its citizens and ensure availability of safe blood components in the near future.